Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00051) | |||||
---|---|---|---|---|---|
Name |
Auranofin
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
34031-32-8; AURANOFIN; (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate; BCP08217; MMV688978; SKF 39162; AKOS026750078; FT-0662343; 1-Thio-; A-D-glucopyranosatotriethylphosphine gold-2,3,4,6-tetraacetate; 3,4,5-Triacetyloxy-6-(acetyloxymethyl) oxane-2-thiolate triethylphosphanium; gold(1+);3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane; SKF-39162; SKF-D-39162; SKF 39162; SKF D 39162; SKFD-39162; SKFD39162
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Rheumatoid arthritis | ICD-11: FA20 | [1] | ||
PubChem CID | |||||
Formula |
C20H34AuO9PS
|
||||
Canonical SMILES |
CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+]
|
||||
InChI |
1S/C14H20O9S.C6H15P.Au/c1-6(15)19-5-10-11(20-7(2)16)12(21-8(3)17)13(14(24)23-10)22-9(4)18;1-4-7(5-2)6-3;/h10-14,24H,5H2,1-4H3;4-6H2,1-3H3;/q;;+1/p-1
|
||||
InChIKey |
AUJRCFUBUPVWSZ-UHFFFAOYSA-M
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=24199313"></iframe>
|
||||
3D MOL is unavailable | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 678.5 | Topological Polar Surface Area | 115 | |
XlogP | N.A. | Complexity | 532 | ||
Heavy Atom Count | 32 | Rotatable Bond Count | 12 | ||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 10 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Auranofin 3 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium lauryl sulfate; Fd&c red no. 40; Benzyl alcohol; D&c red no. 33; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Cetylpyridinium chloride; Titanium dioxide; Povidone; Cellulose, microcrystalline; Gelatin; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Prometheus Laboratories; Sebela Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
D&C red no. 33 | DIG Info | Solute carrier SLCO2B1 (Ki = 58.1 uM) | [3] | |||
Benzyl alcohol | DIG Info | Indoleamine 2,3-dioxygenase 1 (IC50 = 1400 nM) | [4] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Cetylpyridinium chloride | DIG Info | Dopamine D3 receptor (IC50 = 0.55 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.